# OnCo record vitruviae (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/vitruviae/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "vitruviae" ;
  schema:name "Vitruviae"@en ;
  schema:description "Vitruviae develops immune therapies that recognise sugars and fats found on the surface of cancer cells. Its first medicine, VTRU200, is planned for an early trial in acute myeloid leukaemia and other blood cancers and solid tumours."@en ;
  schema:url <https://onco.cc/companies/vitruviae/>, <https://vitruviae.com/> ;
  schema:dateModified "2026-10-29"^^xsd:date ;
  schema:citation <https://vitruviae.com/>, <https://clinicaltrials.gov/study/NCT07749976> ;
  schema:addressCountry "US" ;
  onco:cancers <https://onco.cc/cancers/aml/>, <https://onco.cc/cancers/mds-higher-risk/>, <https://onco.cc/cancers/dlbcl/> ;
  onco:sections <https://onco.cc/fronts/immunotherapy/> ;
  onco:technologies <https://onco.cc/technologies/trispecific-antibodies/>, <https://onco.cc/technologies/t-cell-engager/> ;
  onco:targets <https://onco.cc/targets/cd3/> .